Correlation Of Terrestrial gamma flashes, Electric fields, and Lightning strikes (COTEL) in thunderstorms using networked balloon payloads developed by university and community college students

High energy gamma ray flashes from terrestrial sources have been observed by satellites for decades, but the actual mechanism, assumed to be thunderstorm lightning, has yet to be fully characterized. The goal of COTEL, funded by NASA through the University Student Instrument Project (USIP) program, is to correlate in time TGF events, lightning strikes, and electric fields inside of thunderstorms. This will be accomplished using a small network of balloon-borne payloads suspended in and around thunderstorm environments. The payloads will detect and timestamp gamma radiation bursts, lightning strikes, and the intensity of localized electric fields. While in flight, data collected by the payloads will be transmitted to a ground station in real-time and will be analyzed post-flight to investigate potential correlations between lightning, TGFs, and electric fields. The ground station system that will be used for COTEL was developed for the Eclipse 2017 ballooning project, and was used during flight operations on the day of the eclipse. The COTEL student team is in its second year of effort having spent the first year developing the basic balloon payloads and ground tracking system. Currently the team is focusing on prototype electric field and gamma radiation detectors. Testing and development of these systems will continue into 2018, and flight operations will take place during the spring 2018 Louisiana thunderstorm season. The poster will cover the student team effort in developing said system, an overview of the system architecture, balloon flight tests conducted to date, preliminary results from prototype detectors, and future plans

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

Addressing onsite sampling in recreation site choice models

Independent experts and politicians have criticized statistical analyses of recreation behavior, which rely upon onsite samples due to their potential for biased inference. The use of onsite sampling usually reflects data or budgetary constraints, but can lead to two primary forms of bias in site choice models. First, the strategy entails sampling site choices rather than sampling individuals--a form of bias called endogenous stratification. Under these conditions, sample choices may not reflect the site choices of the true population. Second, exogenous attributes of the individuals sampled onsite may differ from the attributes of individuals in the population--the most common form in recreation demand is avidity bias. We propose addressing these biases by combining two the existing methods: Weighted Exogenous Stratification Maximum Likelihood estimation and propensity score estimation. We use the National Marine Fisheries Service's Marine Recreational Fishing Statistics Survey to illustrate methods of bias reduction, employing both simulated and empirical applications. We find that propensity score based weights can significantly reduce bias in estimation. Our results indicate that failure to account for these biases can overstate anglers' willingness to pay for improvements in fishing catch, but weighted models exhibit higher variance of parameter estimates and willingness to pay.Onsite sampling Propensity score weighting Recreation demand Random utility models

Higher Than Normal Plasma Interleukin-6 Concentrations in Cancer Patients With Depression: Preliminary Findings

OBJECTIVE: This study investigated whether cancer patients with and without major depression exhibit immune system abnormalities similar to those reported in medically healthy, depressed subjects without cancer. METHOD: The study subjects consisted of patients diagnosed with pancreatic, esophageal, or breast cancer. Other groups consisted of subjects with major depression (without cancer) and healthy comparison subjects. Subjects' diagnoses were made with the Structured Clinical Interview for DSM-III-R. Severity of depression was measured with the Hamilton Depression Rating Scale. Plasma concentrations of interleukin-6 (IL-6) and postdexamethasone cortisol were measured. RESULTS: Cancer patients with depression had markedly higher plasma concentrations of IL-6 than healthy comparison subjects and cancer patients without depression. Although significant correlations were found between Hamilton depression scale scores and plasma concentrations of postdexamethasone cortisol, no significant correlations were found between plasma IL-6 and postdexamethasone cortisol concentrations. CONCLUSIONS: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression

Correlation Of Terrestrial gamma flashes, Electric fields, and Lightning strikes (COTEL) in thunderstorms using networked balloon payloads developed by university and community college students

High energy gamma ray flashes from terrestrial sources have been observed by satellites for decades, but the actual mechanism, assumed to be thunderstorm lightning, has yet to be fully characterized. The goal of COTEL, funded by NASA through the University Student Instrument Project (USIP) program, is to correlate in time TGF events, lightning strikes, and electric fields inside of thunderstorms. This will be accomplished using a small network of balloon-borne payloads suspended in and around thunderstorm environments. The payloads will detect and timestamp gamma radiation bursts, lightning strikes, and the intensity of localized electric fields. While in flight, data collected by the payloads will be transmitted to a ground station in real-time and will be analyzed post-flight to investigate potential correlations between lightning, TGFs, and electric fields. The ground station system that will be used for COTEL was developed for the Eclipse 2017 ballooning project, and was used during flight operations on the day of the eclipse. The COTEL student team is in its second year of effort having spent the first year developing the basic balloon payloads and ground tracking system. Currently the team is focusing on prototype electric field and gamma radiation detectors. Testing and development of these systems will continue into 2018, and flight operations will take place during the spring 2018 Louisiana thunderstorm season. The poster will cover the student team effort in developing said system, an overview of the system architecture, balloon flight tests conducted to date, preliminary results from prototype detectors, and future plans